Xxera/openscience/retractions

Record #20221

Sensitizing Estrogen Receptor–negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor

Shu Chuan Weng, Yoko Kashida, Samuel K Kulp, Dasheng Wang, Robert W Bruegggemeier, Charles L Shapiro, Ching Shih Chen

Journal

Molecular Cancer Therapeutics

Publisher

American Association for Cancer Research

Original paper date

Apr 15, 2008

Original DOI

10.1158/1535-7163.MCT-07-0434

Country

🇺🇸 United States

Institution

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio · Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular (HSC) Medicine - Obstetrics/Gynecology (HSC) Medicine - Oncology

Citation lifecycle

How this paper is being cited

Pre-retraction

53

Same day

1

Post-retraction

13

% post-retraction

19.4%

~4.8 citations/yr before retraction · ~1.7 citations/yr after

— citing papers

Who is still citing this work

Loading…